Literature DB >> 33793338

Role of the Peroxisome Proliferator Activated Receptors in Hypertension.

Shi Fang1,2, M Christine Livergood3, Pablo Nakagawa1, Jing Wu1, Curt D Sigmund1.   

Abstract

Nuclear receptors represent a large family of ligand-activated transcription factors which sense the physiological environment and make long-term adaptations by mediating changes in gene expression. In this review, we will first discuss the fundamental mechanisms by which nuclear receptors mediate their transcriptional responses. We will focus on the PPAR (peroxisome proliferator-activated receptor) family of adopted orphan receptors paying special attention to PPARγ, the isoform with the most compelling evidence as an important regulator of arterial blood pressure. We will review genetic data showing that rare mutations in PPARγ cause severe hypertension and clinical trial data which show that PPARγ activators have beneficial effects on blood pressure. We will detail the tissue- and cell-specific molecular mechanisms by which PPARs in the brain, kidney, vasculature, and immune system modulate blood pressure and related phenotypes, such as endothelial function. Finally, we will discuss the role of placental PPARs in preeclampsia, a life threatening form of hypertension during pregnancy. We will close with a viewpoint on future research directions and implications for developing novel therapies.

Entities:  

Keywords:  blood pressure; gene expression; hypertension; preeclampsia; pregnancy

Mesh:

Substances:

Year:  2021        PMID: 33793338      PMCID: PMC8020861          DOI: 10.1161/CIRCRESAHA.120.318062

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   23.213


  186 in total

1.  Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent.

Authors:  Dallas C Jones; Xiaohong Ding; Raymond A Daynes
Journal:  J Biol Chem       Date:  2001-11-28       Impact factor: 5.157

2.  Evidence implicating peroxisome proliferator-activated receptor-γ in the pathogenesis of preeclampsia.

Authors:  Fergus P McCarthy; Sascha Drewlo; Fred A English; John Kingdom; Edward J Johns; Louise C Kenny; Sarah K Walsh
Journal:  Hypertension       Date:  2011-09-19       Impact factor: 10.190

Review 3.  Endogenous ligands for nuclear receptors: digging deeper.

Authors:  Michael Schupp; Mitchell A Lazar
Journal:  J Biol Chem       Date:  2010-10-18       Impact factor: 5.157

4.  Troglitazone lowers blood pressure and enhances insulin sensitivity in Watanabe heritable hyperlipidemic rabbits.

Authors:  K Saku; B Zhang; T Ohta; K Arakawa
Journal:  Am J Hypertens       Date:  1997-09       Impact factor: 2.689

5.  Autonomic contribution to blood pressure and metabolism in obesity.

Authors:  Cyndya Shibao; Alfredo Gamboa; Andre Diedrich; Andrew C Ertl; Kong Y Chen; Daniel W Byrne; Ginnie Farley; Sachin Y Paranjape; Stephen N Davis; Italo Biaggioni
Journal:  Hypertension       Date:  2006-11-20       Impact factor: 10.190

6.  Effect of pioglitazone on arterial baroreflex sensitivity and sympathetic nerve activity in patients with acute myocardial infarction and type 2 diabetes mellitus.

Authors:  Hiroshi Yokoe; Fumio Yuasa; Reisuke Yuyama; Kousuke Murakawa; Yoko Miyasaka; Susumu Yoshida; Satoshi Tsujimoto; Tetsuro Sugiura; Toshiji Iwasaka
Journal:  J Cardiovasc Pharmacol       Date:  2012-06       Impact factor: 3.105

7.  The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses.

Authors:  R B Clark; D Bishop-Bailey; T Estrada-Hernandez; T Hla; L Puddington; S J Padula
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

8.  Conditional deletion of smooth muscle Cullin-3 causes severe progressive hypertension.

Authors:  Larry N Agbor; Anand R Nair; Jing Wu; Ko-Ting Lu; Deborah R Davis; Henry L Keen; Frederick W Quelle; James A McCormick; Jeffrey D Singer; Curt D Sigmund
Journal:  JCI Insight       Date:  2019-06-11

9.  PPAR gamma/RXR alpha heterodimers are involved in human CG beta synthesis and human trophoblast differentiation.

Authors:  A Tarrade; K Schoonjans; J Guibourdenche; J M Bidart; M Vidaud; J Auwerx; C Rochette-Egly; D Evain-Brion
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

10.  Activation of nuclear factor erythroid 2-related factor 2 coordinates dimethylarginine dimethylaminohydrolase/PPAR-γ/endothelial nitric oxide synthase pathways that enhance nitric oxide generation in human glomerular endothelial cells.

Authors:  Zaiming Luo; Shakil Aslam; William J Welch; Christopher S Wilcox
Journal:  Hypertension       Date:  2015-02-17       Impact factor: 10.190

View more
  4 in total

Review 1.  Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance.

Authors:  Krzysztof Mińczuk; Marta Baranowska-Kuczko; Anna Krzyżewska; Eberhard Schlicker; Barbara Malinowska
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

Review 2.  Salt-Sensitivity of Blood Pressure and Insulin Resistance.

Authors:  Lale A Ertuglu; Fernando Elijovich; Cheryl L Laffer; Annet Kirabo
Journal:  Front Physiol       Date:  2021-12-13       Impact factor: 4.566

3.  Regulation of Epigenetic Modifications in the Placenta during Preeclampsia: PPARγ Influences H3K4me3 and H3K9ac in Extravillous Trophoblast Cells.

Authors:  Sarah Meister; Laura Hahn; Susanne Beyer; Corinna Paul; Sophie Mitter; Christina Kuhn; Viktoria von Schönfeldt; Stefanie Corradini; Kritika Sudan; Christian Schulz; Theresa Maria Kolben; Sven Mahner; Udo Jeschke; Thomas Kolben
Journal:  Int J Mol Sci       Date:  2021-11-18       Impact factor: 5.923

4.  RhoBTB1 reverses established arterial stiffness in angiotensin II-induced hypertension by promoting actin depolymerization.

Authors:  Shi Fang; Jing Wu; John J Reho; Ko-Ting Lu; Daniel T Brozoski; Gaurav Kumar; Alec M Werthman; Sebastiao Donato Silva; Patricia C Muskus Veitia; Kelsey K Wackman; Angela J Mathison; Bi Qing Teng; Chien-Wei Lin; Frederick W Quelle; Curt D Sigmund
Journal:  JCI Insight       Date:  2022-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.